Alternatively, we suggest using this opportunity to take a little break from work and read some of the interesting articles below. There are various types of cutaneous LE, classified as acute, subacute, intermittent and chronic cutaneous LE. Would chloroquine in a sickle cell patient be harmful Chloroquine-primaquine-phosphate tablets Chloroquine autophagy inhibitor Chloroquine solubility Background. Discoid lupus erythematosus DLE is a form of skin inflammation which occurs particularly on sun-exposed skin and can cause forms of cutaneous lupus erythematosus are most common in women of childbearing age, which is important because some treatments, including thalidomide and acitretin, can cause birth defects, and hydroxychloroquine may cause damage to the eye or ear. We made the diagnosis of chronic cutaneous lupus erythematosus LE with discoid and hypertrophic LE lesions on the face and the right upper arm, respectively. After confirming by fundoscopy that the patient had no retinopathy, the patient was administrated 200 mg/day 4.65 mg/kg per day of oral hydroxychloroquine HCQ. Hydroxychloroquine Plaquenil Chloroquine Aralen Quinacrine Atabrine What are anti-malarial drugs, and why are they used to treat lupus? Hydroxychloroquine Plaquenil, chloroquine Aralen, and quinacrine Atabrine are medications that were originally used to prevent or treat malaria. Acute cutaneous LE affects at least 50% of patients with systemic lupus erythematosus (SLE). Specific features of acute cutaneous LE may include: See more images of systemic lupus erythematosus. The revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI) can be used to assess disease activity and damage. Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine Cutaneous Lupus Erythematosus Current Treatment Options SpringerLink, Hypertrophic lupus erythematosus successfully treated with. Plaquenil aptt testInj chloroquine dosageWhen my hydroxychloroquine isn't workingChloroquine us brand nameHow does hydroxychloroquine work in sle The antimalarial quinine was first used to treat cutaneous lupus in 1834. Subsequent reports in 19 showed good results with another quinine-like drug in the treatment of both discoid and subacute cutaneous lupus. In 1941, discoid lupus patients were treated successfully with Atabrine, a compound developed in Germany in the 1920s. Drug spotlight on hydroxychloroquine Lupus Foundation of.. Treating Lupus with Anti-Malarial Drugs Johns Hopkins.. PDF Treatment of Cutaneous Lupus - ResearchGate. Aug 07, 2018 Subacute cutaneous lupus erythematosus SCLE is a nonscarring, non–atrophy-producing, photosensitive dermatosis. SCLE commonly develops in sun-exposed areas, including the upper back, shoulders, extensor arms, neck, and upper torso, while the face is often spared. Cutaneous Lupus Erythematosus. Lupus is an autoimmune disease, which affects multiple organs and systems in the body. An individual's own immune system attacks various cells causing a wide variety of signs and symptoms. With regards to the skin, there are lupus-specific skin lesions and non-specific skin lesions. The antimalarial agents chloroquine CQ and hydroxychloroquine HCQ are considered to be effective for the treatment of cutaneous lupus erythematosus CLE and the symptoms associated with systemic lupus erythematosus SLE such as rashes, joint pain, and fatigue.